X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Fermenta Biotech Ltd.
BSE CODE: 506414   |   NSE CODE: NA   |   ISIN CODE : INE225B01021   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 359.00
-0.7 ( -0.19% )
 
Prev Close ( Rs.)
359.70
Open ( Rs.)
366.00
 
High ( Rs.)
366.85
Low ( Rs.)
359.00
 
Volume
14195
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)23.18  -6.49  -19.75  10.48  18.01  
   CEPS(Rs)31.12  1.72  -11.27  18.69  24.61  
   DPS(Rs)2.50  1.25  1.25  1.25  2.50  
   Book NAV/Share(Rs)130.16  104.42  111.86  132.17  124.26  
   Tax Rate(%)9.14  -306.79  1.68  28.96  17.81  
Margin Ratios          
   Core EBITDA Margin(%)23.17  12.16  11.85  19.77  25.38  
   EBIT Margin(%)20.73  4.17  -11.13  15.64  22.08  
   Pre Tax Margin(%)17.29  -1.50  -17.63  10.97  16.96  
   PAT Margin (%)15.71  -6.10  -17.33  7.79  13.94  
   Cash Profit Margin (%)21.09  1.61  -9.89  13.90  19.04  
Performance Ratios          
   ROA(%)11.14  -3.02  -7.98  4.08  8.05  
   ROE(%)19.85  -6.00  -16.19  8.18  15.63  
   ROCE(%)19.07  2.56  -6.18  9.85  14.54  
   Asset Turnover(x)0.71  0.50  0.46  0.52  0.58  
   Sales/Fixed Asset(x)1.17  0.88  1.07  1.28  1.56  
   Working Capital/Sales(x)3.53  3.97  8.08  3.02  3.24  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.85  1.13  0.93  0.78  0.64  
   Receivable days83.65  85.90  102.78  100.64  84.96  
   Inventory Days73.37  111.94  132.79  123.42  120.58  
   Payable days154.43  181.65  140.63  115.51  137.08  
Valuation Parameters          
   PER(x)11.80  0.00  0.00  19.62  13.89  
   PCE(x)8.79  88.27  -9.49  11.01  10.17  
   Price/Book(x)2.10  1.45  0.96  1.56  2.01  
   Yield(%)0.91  0.83  1.17  0.61  1.00  
   EV/Net Sales(x)1.96  1.67  1.43  2.06  2.44  
   EV/Core EBITDA(x)7.52  11.27  9.91  9.47  8.98  
   EV/EBIT(x)9.47  40.09  -12.84  13.17  11.05  
   EV/CE(x)1.73  1.15  0.85  1.05  1.27  
   M Cap / Sales1.85  1.42  0.94  1.53  1.94  
Growth Ratio          
   Net Sales Growth(%)40.20  -6.64  -15.22  4.06  24.06  
   Core EBITDA Growth(%)147.17  -4.14  -43.74  -16.79  22.48  
   EBIT Growth(%)597.75  134.93  -160.36  -26.30  21.40  
   PAT Growth(%)460.74  67.12  -288.52  -41.82  -18.38  
   EPS Growth(%)457.10  67.14  -288.45  -41.82  -18.38  
Financial Stability Ratios          
   Total Debt/Equity(x)0.29  0.44  0.67  0.62  0.64  
   Current Ratio(x)1.53  1.43  1.17  1.62  1.54  
   Quick Ratio(x)1.12  0.99  0.70  1.00  0.92  
   Interest Cover(x)6.02  0.74  -1.72  3.35  4.31  
   Total Debt/Mcap(x)0.14  0.30  0.69  0.39  0.31